Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Prednisolone for Esophageal Stricture After Surgery
NCT02703376Phase 1Unknown
- Sponsor
- Nagasaki University
- Start
- Jan 2016
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of prednisolone in Esophageal stricture, sponsored by Nagasaki University. Primary endpoints: Number of participants with treatment-related adverse events as assessed by Clavien-Dindo Classification at 12 weeks, Incidence of Adverse Events of Grade 3 and Grade 4 of CTCAE v4.0 at 12 weeks and 2 more. Status: unknown.
02
Drugs
prednisolone
03
Conditions
Esophageal stricture
Beyond the preview
Go deeper on NCT02703376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703376.